The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Free Access

The microbiome‐gut‐brain axis: from bowel to behavior

J. F. Cryan

Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland

Search for more papers by this author
S. M. O’Mahony

Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland

Search for more papers by this author
First published: 08 February 2011
Cited by: 241
Address for Correspondence
John F. Cryan PhD, Cavanagh Pharmacy Building, University College Cork, College Rd, Cork, Ireland.
Tel: +353 21 490 1676; fax: +353 21 490 1656; e‐mail: j.cryan@ucc.ie

Abstract

The ability of gut microbiota to communicate with the brain and thus modulate behavior is emerging as an exciting concept in health and disease. The enteric microbiota interacts with the host to form essential relationships that govern homeostasis. Despite the unique enteric bacterial fingerprint of each individual, there appears to be a certain balance that confers health benefits. It is, therefore, reasonable to note that a decrease in the desirable gastrointestinal bacteria will lead to deterioration in gastrointestinal, neuroendocrine or immune relationships and ultimately disease. Therefore, studies focusing on the impact of enteric microbiota on the host and in particular on the central nervous system are essential to our understanding of the influence of this system. Recent studies published in this Journal demonstrate that germ‐free mice display alterations in stress‐responsivity, central neurochemistry and behavior indicative of a reduction in anxiety in comparison to conventional mice. Such data offer the enticing proposition that specific modulation of the enteric microbiota may be a useful strategy for stress‐related disorders and for modulating the co‐morbid aspects of gastrointestinal disorders such as irritable bowel syndrome and inflammatory bowel disease.

The gut‐brain axis

The bidirectional signaling between the gastrointestinal tract and the brain is vital for maintaining homeostasis and is regulated at the neural (both central and enteric nervous systems), hormonal and immunological levels. Perturbation of these systems results in alterations in the stress‐response and overall behavior.1 The high co‐morbidity between stress‐related psychiatric symptoms such as anxiety with gastrointestinal disorders including irritable bowel disorder (IBS) and inflammatory bowel disorder (IBD)2, 3 are further evidence of the importance of this axis. However, increasing evidence also suggests that the enteric microbiome greatly impacts on gut‐brain communication leading to the coining of the phrase the brain‐gut enteric microbiota axis1 (illustrated in Fig. 1). The exact mechanisms governing such communication are unclear and most studies to date focus on the impact of altered signaling from the brain to the gut.4, 5 Recent emerging studies are investigating the impact of the guts’ microbiota on brain and behavior. Approaches used to parse the role of gut microbiota on brain function include assessing the impact of probiotic agents, antibiotic‐induced dysbiosis and pathogenic infections6-9 each of which we will discuss below.

Representation of the enteric microbiota‐gut‐brain axis and how anxiety‐like behavior can be measured using the elevated plus maze. Recent studies (refer to text) have shown that perturbations of the enteric microbiota can impact on this axis to alter behavioral responses in animal models.

Germ‐free/gnotobiotic animals

One approach that is being utilized to study the microbiome‐gut‐brain axis is the use of germ‐free animals.10 Germ‐free mice, which are animals devoid of any bacterial contamination, offer the possibility to study the impact of the complete absence of a gastrointestinal microbiota on behavior. Germ‐free mice also allow the study of the impact of a particular entity (e.g. probiotic) on the microbiome‐gut‐brain axis in isolation.10 It should be noted that, while useful research tools in neurogastroenterology, the data from these animal studies are not translational to human disease as they do not represent any true situation in the human population. Despite this, their use has generated exciting data that is leading the way to directly answering the question: can enteric microbiota alter behavior?

Behavioral and neurochemical consequences of growing up germ‐free

Neufeld and colleagues in this issue of this Journal11 use female germ‐free mice to demonstrate that the absence of a conventional microbiota results in a reduction in anxiety behavior in the elevated plus maze, a well validated model of anxiolytic action (see Fig. 1). These authors also show an upregulation in the expression of brain derived neurotrophic factor (BDNF) mRNA in the dentate gyrus of the hippocampus of these germ‐free animals. Brain derived neurotrophic factor is crucial for supporting neuronal survival and encouraging the growth and differentiation of new neurons and synapses and thus is involved in the regulation of multiple aspects of cognitive and emotional behaviors.12 Whilst there is a clear relationship between chronic stress states, major depression and BDNF,13 the association between anxiety and BDNF appears to be more complex with the authors finding positive, negative and no correlation between hippocampal levels and anxiety.14-16 Thus, it is unclear whether the changes in hippocampal BDNF observed in the study of Neufeld and colleagues actually relates to the behavioral changes observed.

Interestingly, and somewhat discordant with the behavioral data, an increase in the stress hormone corticosterone was noted in the plasma of the germ‐free mice. Moreover, a decrease in the NR2B subunit of the NMDA receptor in the amygdala, but not hippocampus, of germ‐free animals was observed which the authors speculate may contribute to the anxiolytic‐like effect noted. In addition, a down‐regulation of the 5‐HT1A auto receptor was also present in the dentate gyrus of the germ‐free mice.11

These data together provide important and direct evidence that microbiota can influence brain and behavior, in this case anxiety. They build on previous studies from Sudo and colleagues17 which demonstrate that male germ‐free mice have an increased stress response (although no basal changes in hypothalamic pituitary adrenal axis function were noted in these studies) coupled with decreased hippocampal and cortical BDNF, and decreased NR1 (hippocampus) and NR2A (hippocampus and cortex).17 The reasons for the discrepancies between the molecular changes in these studies and that of Neufeld and colleagues are unclear at present. Gender may play a role in such effects. Indeed, recent data from our laboratory show that the neurochemical and endocrine but not immune effects of growing up in a germ‐free environment is only evident in male animals.18 Another important difference between the studies is the method of mRNA expression analysis (in situ hybridization vs quantitative real‐time PCR). One significant caveat to the data generated by Neufeld and colleagues is that their studies were carried out on commercially sourced germ‐free animals and were conducted just 48 h following arrival at their facility. The impact of transport stress and the lack of information regarding gnotobiotic status are two major confounds to the study.19 Moreover, whereas Sudo and colleagues demonstrated that recolonization with Bifidobacteria species reversed the germ‐free induced effects, no attempt at recolonization occurred in Neufeld et al.’s study. However, despite these limitations their work is among the first to show a direct link between anxiety‐related behavior and the microbiota and thus is an exciting and important contribution to the literature.

Probiotics and behavior/central neurotransmitters

Probiotics are beneficial in the treatment of the gastrointestinal symptoms of disorders such as IBS.20 Clinical evidence is mounting to support the role of probiotic intervention in reducing the anxiety and stress response as well as improving mood in IBS patients and those with chronic fatigue.21-23 Recently, a study assessing the effect of a combination of Lactobacillus helveticus and Bifidobacterium longum on both human subjects and rats showed that these probiotics reduced anxiety in animals and had beneficial psychological effects with a decrease in serum cortisol in patients.24 While the mechanism of action is not known, some probiotics do have the potential to lower inflammatory cytokines,20, 25 decrease oxidative stress and improve nutritional status.21 The modulation of systemic inflammatory cytokines and oxidative stress could potentially lead to increased BDNF,21 known to be involved in depression and anxiety.13, 14

Lactobacillus reuteri, a potential probiotic known to modulate the immune system26 decreases anxiety as measured on the elevated plus maze as well as reducing the stress‐induced increase of corticosterone in mice.27 This probiotic alters the mRNA expression of both GABAA and GABAB receptors in the central nervous system. Alterations in these receptors are associated with anxious and depressive‐like behaviors in animal models. Vagotomy in these animals prevented the anxiolytic and antidepressant effects of this bacterium as well as the effects on the central GABA receptors. This suggests that parasympathetic innervation is necessary for L. reuteri to participate in the microbiota‐brain interaction.

Previous studies28 have shown that probiotic agents can modulate antidepressant‐like behavior with Bifidobacterium infantis having antidepressant properties in the forced swim test, a well‐established model in the evaluation of pharmacological antidepressant activity.29 Chronic B. infantis administration also led to a suppression in stimulation‐induced increases in peripheral pro‐inflammatory cytokines and increases in plasma tryptophan,28 both of which have been implicated in depression.30, 31 We have also investigated the impact of B. infantis on a preclinical model of IBS (maternal separation model)32 and showed that this bacterium was able to reverse some of the early‐life stress‐induced changes.

Taken together, it is clear that certain probiotic strains can modulate various aspects of the microbiome‐gut‐brain axis.33 However, these effects are bacterial strain dependent and care must be taken in extrapolating data obtained from one organism to another. Nonetheless, the accumulating data suggest a clear ability of probiotic and potential probiotic strains to modulate brain and behavior.

Antibiotic intervention and behavior

The administration of broad‐spectrum antibiotics, frequently used in both adult and pediatric clinical practices, has been shown to reduce the biodiversity of the fecal microbiota and delay the colonization by some probiotic strains, e.g., lactobacilli.34 Antibiotic disruption of the gut flora has also been linked to expression of functional gastrointestinal symptoms.35

The use of antimicrobial drugs is one of the most common artificial ways to induce intestinal dysbiosis in experimental animals. Preliminary data from Bercik and Collins6 show that oral administration of neomycin and bacitracin along with the antifungal agent primaricin to perturb the microbiota for 7 days in adult BALB/c mice induced altered behavior when tested using the step‐down and the light/dark box tests.6 These data could be interpreted as a reduction in anxiety in antibiotic treated mice or alternatively an increase in locomotor behavior. Clearly, future studies examining the behavioral consequences of adult antibiotic use and mechanisms underlying such changes are warranted.

Previously we have shown that stress in early life leads to altered behavior and fecal microbiota in adulthood in rats.36 In line with this work we assessed the impact of perturbations in microbiota on adult behavior.37 Therefore, we induced dysbiosis through the administration of the antibiotic vancomycin to neonatal rat pups. In this case behavior was measured in adulthood, 6 weeks after cessation of treatment. Our prediction was that an altered microbiota in neonatal life would lead to behavioral changes still present in adulthood. Intriguingly, although we did not see any alteration in anxiety or cognitive behavior, an increase in visceral pain behaviors was evident. Thus, there appears to be a temporal dissociation between the onset of microbiota disturbance and the alterations in anxiety‐related behavior.

Infection, central activation and behavior

Studies observing behavior of animals following infection offer a better representation of the human condition in certain instances. Infections due to enteric bacterial pathogens causes acute mucosal inflammation38 and is noted as a risk factor for the development of postinfectious IBS.39, 40 However, whether these short‐ and long‐term intestinal changes affect behavior is not well defined.

In a recent series of studies, Bercik et al.,41 sought to examine how chronic gut inflammation alters behavior; they infected mice with Trichuris muris, which is very closely related to the human parasite T. trichiura, and examined alterations in anxiety‐like behavior and hippocampal BDNF. They demonstrated that treatment with the anti‐inflammatory agents etanercept, and to a lesser degree of budesonide, normalized behavior, reduced cytokine and kynurenine levels, but did not influence BDNF expression. Moreover, the probiotic B. longum normalized behavior and BDNF mRNA but did not affect cytokine or kynurenine levels. Vagotomy did not prevent anxiety‐like behavior in the infected mice. Clearly the mechanism of action of these interventions differ, nevertheless all three normalized the behavior induced by the infection indicating that the microbiota may signal to the brain through multiple routes.

There have been an increasing number of studies using Citrobacter rodentium as an infectious agent to investigate gut‐brain axis function. Citrobacter rodentium does not affect baseline behavior when tested 14 and 30 days after infection in C57BL/6 mice.10 Yet when CF‐1 mice were infected and behavior tested at 7–8 h following infection, there was an increase in anxious‐like behavior.42 Psychological stress is known to affect intestinal barrier function8 and host‐microbe interactions.43 With this in mind, the authors stressed the infected mice acutely which induced memory dysfunction following the resolution of the infection some 30 days later. This dysfunction was prevented by pretreatment with a commercially available combination of probiotics. This pretreatment also ameliorated serum corticosterone levels as well as preventing alterations in hippocampal BDNF and central c‐fos expression. Germ‐free mice were also included in this study and they displayed impaired memory both with and without the acute stress. Intriguingly, these germ‐free mice were not less anxious when compared to controls which is at odds with the data presented by Neufield et al.11 This maybe due to the fact that different tests were employed, the light‐dark box test in the former as opposed to the elevated plus maze. This study highlights the joint impact of infection and stress on the central nervous system and also points to the fact that a commensal gut flora is necessary for both spatial and working memory. Since no overt systemic inflammation was observed and increased neuronal activation in vagal ganglia was seen, it is proposed that the gut to brain signaling in this instance was mediated through the vagus nerve.42

Another example of the impact of enteric microbiota affecting brain function was seen when Camplobacter jejuni, a food borne pathogen, led to activation of brain regions that are involved in the processing of gastrointestinal sensory information in mice.44 c‐fos was increased in visceral sensory nuclei in the brainstem (1 and 2 days after inoculation) and the paraventricular nucleus of the hypothalamus (2 days after inoculation). An interesting twist to this study is that the infection did not induce a system inflammatory response. Therefore, the vagal nerve may be implicated in the signaling of this pathogen and its effect on brain activation. These authors also noted that after 7 h, C. jejuni increased anxious‐like behavior in the hole board test and the level of anxiety was proportional to neuronal activation as assessed by the number of c‐fos expressing cells in the bed nucleus of the stria terminalis a key component of the extended amygdala fear system.45 These and other findings by the same authors9 allude to the amygdala and the bed nucleus stria of terminalis as interfaces between gastrointestinal pathogenic challenge and brain regions that are associated with the behavioral responses to stress. They also support the notion that these nuclei are anatomical substrates by which viscerosensory stimuli can influence behavior.

The vagus nerve is involved in the transmission of signals from the gastrointestinal tract to the central nervous system during a Salmonella typhimurium infection.46 To establish this, rats were infected with the bacteria and vagotomy was performed in half of the animals 28 days prior to the infection. Salmonella increased inflammation in the ileum and the mesenteric lymph nodes while decreased aspects of the systemic immune response. c‐fos expression was increased due to infection in the paraventricular nucleus and the supraoptic nucleus. Vagotomy prevented these infection associated changes. These results again imply that the vagus plays an important role in the transmission of immune information from gut to brain and also in homeostasis associated with the immune system.

Conclusions

All of the studies outlined above indicate that there is an increasing need to understand the molecular, cellular and physiological basis of enteric microbiome‐gut‐brain communication. The article by Neufeld and colleagues11 illustrates that the complete absence of a conventional microbiota leads to decreased anxiety‐like behaviors as well as alterations in central neurochemistry. Future studies will provide insight into the development of novel treatment strategies (probiotics or pharmacological), for gastrointestinal disorders that are associated with an altered signaling from the bowel to the brain.

Acknowledgments

The Alimentary Pharmabiotic Centre is a research centre funded by Science Foundation Ireland (SFI), through the Irish Government’s National Development Plan. The authors and their work were supported by SFI (grant numbers: 02/CE/B124 and 07/CE/B1368). The centre is also funded by GlaxoSmithKline. JFC is also funded by European Community’s Seventh Framework Programme; Grant Number: FP7/2007‐2013, Grant Agreement 201714. The authors would like to thank Dr. Marcela Julio‐Pieper for assisting with the artwork in this manuscript.

    Competing interests

    The authors have no competing interests.

    Number of times cited: 241

    • , Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review, Journal of Neurogastroenterology and Motility, 24, 1, (30), (2018).
    • , Intestinal microbiome-gut-brain axis and irritable bowel syndromeIntestinale Mikrobiom-Darm-Hirn-Achse und Reizdarmsyndrom, Wiener Medizinische Wochenschrift, 10.1007/s10354-017-0592-0, 168, 3-4, (62-66), (2017).
    • , The nasal microbiome mirrors and potentially shapes olfactory function, Scientific Reports, 8, 1, (2018).
    • , Steroids, stress and the gut microbiome‐brain axis, Journal of Neuroendocrinology, 30, 2, (2018).
    • , Reproducibility in Biomedical Research, Research in the Biomedical Sciences, 10.1016/B978-0-12-804725-5.00001-X, (1-66), (2018).
    • , Interactions between species introduce spurious associations in microbiome studies, PLOS Computational Biology, 14, 1, (e1005939), (2018).
    • , Is the microbiome influencing patient care in lower urinary tract dysfunction? Report from the ICI‐RS 2017, Neurourology and Urodynamics, 37, S4, (S93-S98), (2018).
    • , Autism Spectrum Disorder, Integrative Medicine, 10.1016/B978-0-323-35868-2.00008-6, (64-73.e4), (2018).
    • , Modulation of gut microbiota by dietary supplementation with tuna oil and algae oil alleviates the effects of D-galactose-induced ageing, Applied Microbiology and Biotechnology, (2018).
    • , Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia, Mediators of Inflammation, 2018, (1), (2018).
    • , Effect of dietary synbiotic supplement on behavioral patterns and growth performance of broiler chickens reared under heat stress, Poultry Science, (2018).
    • , Environmental microbiology to the rescue of planet earth, Environmental Microbiology, 20, 6, (1910-1916), (2018).
    • , Anatomy and Brain Development, Neurocounseling, (1-26), (2017).
    • , An Overview of Probiotic Research, Probiotic Dairy Products, (293-357), (2017).
    • , GABA‐producing Bifidobacterium dentium modulates visceral sensitivity in the intestine, Neurogastroenterology & Motility, 29, 1, (2016).
    • , Basic Definitions and Concepts: Organization of the Gut Microbiome, Gastroenterology Clinics of North America, 46, 1, (1), (2017).
    • , New mechanisms of the TCM spleen-based treatment of immune thrombocytopenia purpura from the perspective of blood neurotransmitters, Journal of Traditional Chinese Medical Sciences, 4, 2, (106), (2017).
    • , Inhibition of corticotropin-releasing hormone receptor 1 and activation of receptor 2 protect against colonic injury and promote epithelium repair, Scientific Reports, 7, (46616), (2017).
    • , Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals, Nutrients, 9, 3, (284), (2017).
    • , Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice, European Journal of Nutrition, 56, 1, (179), (2017).
    • , Gut Microbiota and the Gut-Brain Axis, Psychosomatic Medicine, 79, 8, (874), (2017).
    • , Nicotine Alters the Gut Microbiome and Metabolites of Gut–Brain Interactions in a Sex-Specific Manner, Chemical Research in Toxicology, 30, 12, (2110), (2017).
    • , Exercise Modifies the Gut Microbiota with Positive Health Effects, Oxidative Medicine and Cellular Longevity, 2017, (1), (2017).
    • , Probiotics and Subclinical Psychological Symptoms in Healthy Participants: A Systematic Review and Meta-Analysis, The Journal of Alternative and Complementary Medicine, 23, 4, (249), (2017).
    • , The third tier in treatment: Attending to the growing connection between gut health and emotional well-being, Health Psychology Open, 4, 2, (205510291772433), (2017).
    • , Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease, Current Behavioral Neuroscience Reports, 4, 4, (361), (2017).
    • , Peptides as Quorum Sensing Molecules: Measurement Techniques and Obtained Levels In vitro and In vivo, Frontiers in Neuroscience, 11, (2017).
    • , Applying a Biosocial Perspective to Address Childhood Diarrhea-Related Morbidity and Mortality, Handbook of Famine, Starvation, and Nutrient Deprivation, 10.1007/978-3-319-40007-5_85-1, (1-19), (2017).
    • , The microbiome and disorders of the central nervous system, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2017.06.016, 160, (1-13), (2017).
    • , An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data, BMC Bioinformatics, 18, 1, (2017).
    • , Intervention strategies for cesarean section–induced alterations in the microbiota-gut-brain axis, Nutrition Reviews, 75, 4, (225), (2017).
    • , Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats, PLOS ONE, 12, 2, (e0172339), (2017).
    • , Diet and Supplementation Targeted for Autism Spectrum Disorder, Handbook of Treatments for Autism Spectrum Disorder, 10.1007/978-3-319-61738-1_22, (397-425), (2017).
    • , Brain changes detected by functional magnetic resonance imaging and spectroscopy in patients with Crohn's disease, World Journal of Gastroenterology, 10.3748/wjg.v23.i20.3607, 23, 20, (3607), (2017).
    • , A Return to Wisdom: Using Sickness Behaviors to Integrate Ecological and Translational Research, Integrative and Comparative Biology, 10.1093/icb/icx051, 57, 6, (1204-1213), (2017).
    • , Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Scientific Reports, 7, (41802), (2017).
    • , Microbiome–Gut–Brain Axis: A Pathway for Improving Brainstem Serotonin Homeostasis and Successful Autoresuscitation in SIDS—A Novel Hypothesis, Frontiers in Pediatrics, 4, (2017).
    • , Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry, Translational Research, 179, (223), (2017).
    • , Gastrointestinal Symptom Distress is Associated With Worse Mental and Physical Health-Related Quality of Life, JAIDS Journal of Acquired Immune Deficiency Syndromes, 75, 1, (67), (2017).
    • , The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists, Microorganisms, 5, 4, (66), (2017).
    • , Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial, BMJ Paediatrics Open, 1, 1, (e000176), (2017).
    • , Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle?, Neuroscience, 10.1016/j.neuroscience.2015.09.068, 342, (37-54), (2017).
    • , Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders, Reviews in the Neurosciences, 28, 7, (2017).
    • , Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress, Gastrointestinal Pharmacology, 10.1007/164_2016_128, (219-246), (2017).
    • , The gut microbiota as a key regulator of visceral pain, PAIN, 10.1097/j.pain.0000000000000779, 158, (S19-S28), (2017).
    • , Examining the Link Between the Human Microbiome and Antisocial Behavior: Why Criminologists Should Care About Biochemistry, Too, Deviant Behavior, (1), (2017).
    • , Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry, Expert Review of Proteomics, 14, 9, (809), (2017).
    • , Close association between intestinal microbiota and irritable bowel syndrome, European Journal of Clinical Microbiology & Infectious Diseases, 36, 12, (2303), (2017).
    • , Neuroinflammatory genes associated with post-traumatic stress disorder, Psychiatric Genetics, 27, 1, (1), (2017).
    • , Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial, Journal of Gastroenterology, 52, 4, (432), (2017).
    • , Gastrointestinal Functions ☆, Reference Module in Neuroscience and Biobehavioral Psychology, 10.1016/B978-0-12-809324-5.03628-2, (2017).
    • , The Gut Microbiota and Alzheimer’s Disease, Journal of Alzheimer's Disease, 58, 1, (1), (2017).
    • , A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls, BMC Neurology, 10.1186/s12883-017-0863-9, 17, 1, (2017).
    • , The maternal control in the embryonic development of zebrafish, General and Comparative Endocrinology, 10.1016/j.ygcen.2016.03.028, 245, (55-68), (2017).
    • , Cross‐cultural and psychological issues in irritable bowel syndrome, Journal of Gastroenterology and Hepatology, 32, 10, (1679-1685), (2017).
    • , Probiotic Supplementation in Preterm: Feeding Intolerance and Hospital Cost, Nutrients, 9, 9, (965), (2017).
    • , Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals, Microbiome, 4, 1, (2016).
    • , Gut microbiota: an Indicator to Gastrointestinal Tract Diseases, Journal of Gastrointestinal Cancer, 47, 3, (232), (2016).
    • , Le rôle potentiel du microbiote intestinal dans les troubles psychiatriques majeurs : mécanismes, données fondamentales, comorbidités gastro-intestinales et options thérapeutiques, La Presse Médicale, 45, 1, (7), (2016).
    • , Long-Term Transcriptomic Effects of Prebiotics and Synbiotics Delivered In Ovo in Broiler Chickens, PLOS ONE, 11, 12, (e0168899), (2016).
    • , Bugs, guts and brains and the regulation of food intake and body weight, International Journal of Obesity Supplements, 6, S1, (S8), (2016).
    • , Gut Microbiota-brain Axis, Chinese Medical Journal, 129, 19, (2373), (2016).
    • , Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior, International Journal of Neuropsychopharmacology, 10.1093/ijnp/pyw020, 19, 8, (pyw020), (2016).
    • , Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician, Current Gastroenterology Reports, 18, 9, (2016).
    • , The unusual endoscopic finding in a patient presenting with the chronic duodenal bulb ulcer complicated by hemorrhage, Dokazatel'naya gastroenterologiya, 5, 1, (22), (2016).
    • , What’s bugging your teen?—The microbiota and adolescent mental health, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2016.06.005, 70, (300-312), (2016).
    • , Assessment of sex specific endocrine disrupting effects in the prenatal and pre-pubertal rodent brain, The Journal of Steroid Biochemistry and Molecular Biology, 10.1016/j.jsbmb.2015.08.021, 160, (148-159), (2016).
    • , The Porosity of Autonomy: Social and Biological Constitution of the Patient in Biomedicine, The American Journal of Bioethics, 16, 2, (34), (2016).
    • , Bosom Buddies: The Symbiotic Relationship Between Infants andBifidobacterium longumssp.longumand ssp.infantis. Genetic and Probiotic Features, Annual Review of Food Science and Technology, 7, 1, (1), (2016).
    • , Can attention to the intestinal microbiota improve understanding and treatment of anorexia nervosa?, Expert Review of Gastroenterology & Hepatology, 10, 5, (565), (2016).
    • , Sex differences in the gut microbiome–brain axis across the lifespan, Philosophical Transactions of the Royal Society B: Biological Sciences, 371, 1688, (20150122), (2016).
    • , Gut microbiota regulates key modulators of social behavior, European Neuropsychopharmacology, 10.1016/j.euroneuro.2015.11.002, 26, 1, (78-91), (2016).
    • , Spleen Function and Anxiety in Chinese Medicine: A Western Medicine Perspective, Chinese Medicine, 07, 03, (110), (2016).
    • , A Metagenomic Insight Into the Human Microbiome, Medical and Health Genomics, 10.1016/B978-0-12-420196-5.00009-5, (107-119), (2016).
    • , Chlorella sorokiniana Extract Improves Short-Term Memory in Rats, Molecules, 21, 12, (1311), (2016).
    • , Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome, CNS Neuroscience & Therapeutics, 22, 2, (102-117), (2015).
    • , Microbial modulation of behavior and stress responses in zebrafish larvae, Behavioural Brain Research, 311, (219), (2016).
    • , Reframing the Teenage Wasteland: Adolescent Microbiota-Gut-Brain Axis, The Canadian Journal of Psychiatry, 10.1177/0706743716635536, 61, 4, (214-221), (2016).
    • , Obesity: the new view of the old problem, Dokazatel'naya gastroenterologiya, 5, 1, (16), (2016).
    • , Extracellular vesicles: Pharmacological modulators of the peripheral and central signals governing obesity, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2015.11.002, 157, (65-83), (2016).
    • , Insomnia in Chinese Medicine: The Heart of the Matter, The Journal of Alternative and Complementary Medicine, (2016).
    • , Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms, Parkinsonism & Related Disorders, 27, (1), (2016).
    • , The human urinary microbiome and how it relates to urogynecology, International Urogynecology Journal, 27, 9, (1307), (2016).
    • , From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways, Molecular Psychiatry, 10.1038/mp.2016.50, 21, 6, (738-748), (2016).
    • , Microbes and the mind: emerging hallmarks of the gut microbiota–brain axis, Cellular Microbiology, 18, 5, (632-644), (2016).
    • , Stool-based biomarkers of interstitial cystitis/bladder pain syndrome, Scientific Reports, 10.1038/srep26083, 6, 1, (2016).
    • , Adolescent voluntary exercise attenuated hippocampal innate immunity responses and depressive-like behaviors following maternal separation stress in male rats, Physiology & Behavior, 163, (177), (2016).
    • , Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review, Journal of Neurogastroenterology and Motility, 22, 4, (589), (2016).
    • , Stress and the microbiome: linking glucocorticoids to bacterial community dynamics in wild red squirrels, Biology Letters, 12, 1, (20150875), (2016).
    • , Agavins Increase Neurotrophic Factors and Decrease Oxidative Stress in the Brains of High-Fat Diet-Induced Obese Mice, Molecules, 21, 12, (998), (2016).
    • , Lactobacillus rhamnosusGG Effect on Behavior of Zebrafish During Chronic Ethanol Exposure, BioResearch Open Access, 5, 1, (1), (2016).
    • , Gut Microbiota: The Brain Peacekeeper, Frontiers in Microbiology, 7, (2016).
    • , Host‐microbiome interactions in acute and chronic respiratory infections, Cellular Microbiology, 18, 5, (652-662), (2016).
    • , Good Bugs, Bad Bugs in the Gut: The Role of Microbiota Dysbiosis in Chronic Gastrointestinal Consequences of Infection, The American Journal of Gastroenterology Supplements, 3, 2, (25), (2016).
    • , Alzheimer’s disease and gut microbiota, Science China Life Sciences, 59, 10, (1006), (2016).
    • , Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate, NeuroImage, 10.1016/j.neuroimage.2015.11.018, 125, (988-995), (2016).
    • , Effect of Yoga in the Therapy of Irritable Bowel Syndrome: A Systematic Review, Clinical Gastroenterology and Hepatology, 14, 12, (1720), (2016).
    • , Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases, Journal of Neurogastroenterology and Motility, 10.5056/jnm15146, 22, 2, (201-212), (2016).
    • , The Brain–Gut Axis, Yamada' s Textbook of Gastroenterology, (227-238), (2015).
    • , Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers, Psychopharmacology, 10.1007/s00213-014-3810-0, 232, 10, (1793-1801), (2014).
    • , Neurotransmitters as food supplements: the effects of GABA on brain and behavior, Frontiers in Psychology, 6, (2015).
    • , Role of Probiotics and Prebiotics in the Management of Obesity, Food Microbiology, 10.1201/b19874-10, (157-186), (2015).
    • , Molecular Psychiatry: 20 Years, Molecular Psychiatry, 20, 5, (545), (2015).
    • , Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome, Journal of Gastroenterology, 10.1007/s00535-015-1086-8, 50, 8, (819-830), (2015).
    • , Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome, Psychopharmacology, 232, 8, (1357), (2015).
    • , A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood, Brain, Behavior, and Immunity, 48, (258), (2015).
    • , Probiotics and Neuroprotection, Diet and Nutrition in Dementia and Cognitive Decline, 10.1016/B978-0-12-407824-6.00079-3, (859-868), (2015).
    • , Sugar-coated: exopolysaccharide producing lactic acid bacteria for food and human health applications, Food & Function, 10.1039/C4FO00529E, 6, 3, (679-693), (2015).
    • , Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota, Scientific Reports, 10.1038/srep07259, 4, 1, (2014).
    • , A Combination Supplement of Fructo- and Xylo-Oligosaccharides Significantly Abrogates Oxidative Impairments and Neurotoxicity in Maternal/Fetal Milieu Following Gestational Exposure to Acrylamide in Rat, Neurochemical Research, 40, 9, (1904), (2015).
    • , 20. Probiotics, Compendium of Methods for the Microbiological Examination of Foods, 10.2105/MBEF.0222.025, (2015).
    • , The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment, Psychosomatic Medicine, 77, 9, (969), (2015).
    • , Impact of nutrition on brain development and its neuroprotective implications following preterm birth, Pediatric Research, 77, 1-2, (148), (2015).
    • , Aluminum and Glyphosate Can Synergistically Induce Pineal Gland Pathology: Connection to Gut Dysbiosis and Neurological Disease, Agricultural Sciences, 06, 01, (42), (2015).
    • , Schizophrenia and the gut–brain axis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 56, (155), (2015).
    • , S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults: A pilot study, Advances in Integrative Medicine, 2, 1, (56), (2015).
    • , Neutral Models of Microbiome Evolution, PLOS Computational Biology, 11, 7, (e1004365), (2015).
    • , Animal Models in Biomedical Research, Laboratory Animal Medicine, 10.1016/B978-0-12-409527-4.00034-1, (1497-1534), (2015).
    • , Microbiota Regulation of the Mammalian Gut–Brain Axis, , 10.1016/bs.aambs.2015.02.001, (1-62), (2015).
    • , Dietary magnesium deficiency alters gut microbiota and leads to depressive-like behaviour, Acta Neuropsychiatrica, 10.1017/neu.2015.7, 27, 03, (168-176), (2015).
    • , Systematic review of evidence to support the theory of psychobiotics, Nutrition Reviews, 73, 10, (675), (2015).
    • , Tuning the Brain-Gut Axis in Health and Disease, Current Stem Cell Reports, 1, 1, (60), (2015).
    • , Structural and Functional Characterization of a Novel Family GH115 4-O-Methyl-α-Glucuronidase with Specificity for Decorated Arabinogalactans, Journal of Molecular Biology, 427, 24, (3935), (2015).
    • , A urinary metabolomics study of the metabolic dysfunction and the regulation effect of citalopram in rats exposed to chronic unpredictable mild stress, RSC Advances, 5, 85, (69800), (2015).
    • , Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study, Sleep Science, 8, 3, (124), (2015).
    • , The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review, Pathologie Biologie, 63, 1, (35), (2015).
    • , Microbes on the edge of Occam’s razor, Biology Direct, 10, 1, (2015).
    • , Inulin supplementation during gestation mitigates acrylamide-induced maternal and fetal brain oxidative dysfunctions and neurotoxicity in rats, Neurotoxicology and Teratology, 49, (49), (2015).
    • , Gastrointestinal microbiota in children with autism in Slovakia, Physiology & Behavior, 138, (179), (2015).
    • , The microbiome of the urinary tract—a role beyond infection, Nature Reviews Urology, 12, 2, (81), (2015).
    • , The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938, The Journal of Physiology, 593, 17, (3943-3957), (2015).
    • , The very low birth weight infant microbiome and childhood health, Birth Defects Research Part C: Embryo Today: Reviews, 105, 4, (252-264), (2015).
    • , Development of the infant intestinal microbiome: A bird's eye view of a complex process, Birth Defects Research Part C: Embryo Today: Reviews, 105, 4, (228-239), (2015).
    • , Human Microbiome: When a Friend Becomes an Enemy, Archivum Immunologiae et Therapiae Experimentalis, 63, 4, (287), (2015).
    • , A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial, Pediatric Research, 77, 6, (823), (2015).
    • , Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress, Neuroscience, 310, (561), (2015).
    • , The role of the gut microbiome in the healthy adult status, Clinica Chimica Acta, 451, (97), (2015).
    • , Serotonin, tryptophan metabolism and the brain-gut-microbiome axis, Behavioural Brain Research, 10.1016/j.bbr.2014.07.027, 277, (32-48), (2015).
    • , The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract, Endocannabinoids, 10.1016/bs.irn.2015.10.002, (85-126), (2015).
    • , Broadening the Scope of Collaborative Therapies: Embodied Practices Arising From Neurobiology, Neurocardiology, and Neurogastroenterology, Journal of Systemic Therapies, 34, 4, (1), (2015).
    • , Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance, Scientific Reports, 5, 1, (2015).
    • , Probiotics in Irritable Bowel Syndrome, Journal of Clinical Gastroenterology, 49, (S60), (2015).
    • , Microbial endocrinology: the interplay between the microbiota and the endocrine system, FEMS Microbiology Reviews, 39, 4, (509), (2015).
    • , The microbiome and childhood diseases: Focus on brain‐gut axis, Birth Defects Research Part C: Embryo Today: Reviews, 105, 4, (296-313), (2015).
    • , Microbial endocrinology: host-bacteria communication within the gut microbiome, Journal of Endocrinology, 225, 2, (R21), (2015).
    • , Hitchhiking of host biology by beneficial symbionts enhances transmission, Scientific Reports, 4, 1, (2015).
    • , Probiotics in Functional Gastrointestinal Disorders in Children: Therapy and Prevention, Nutraceuticals and Functional Foods in Human Health and Disease Prevention, 10.1201/b19308-56, (643-650), (2015).
    • , Probiotic actobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation‐induced visceral hypersensitivity in adult rats, Neurogastroenterology & Motility, 26, 12, (1694-1704), (2014).
    • , A Phylogenomic View of Ecological Specialization in the Lachnospiraceae, a Family of Digestive Tract-Associated Bacteria, Genome Biology and Evolution, 6, 3, (703), (2014).
    • , Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms, Antonie van Leeuwenhoek, 106, 1, (141), (2014).
    • , The microbiome: stress, health and disease, Mammalian Genome, 10.1007/s00335-013-9488-5, 25, 1-2, (49-74), (2013).
    • , Stress and food allergy: mechanistic considerations, Annals of Allergy, Asthma & Immunology, 112, 4, (296), (2014).
    • , Pathophysiological responses from human gut microbiome, World Journal of Translational Medicine, 3, 3, (133), (2014).
    • , Autoantibodies and depression, Neuroscience & Biobehavioral Reviews, 40, (62), (2014).
    • , Rational identification of diet-derived postbiotics for improving intestinal microbiota function, Current Opinion in Biotechnology, 10.1016/j.copbio.2013.10.006, 26, (85-90), (2014).
    • , Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats, Neuroscience, 10.1016/j.neuroscience.2014.07.054, 277, (885-901), (2014).
    • , Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory, Psychological Medicine, 44, 07, (1553), (2014).
    • , Relationship between gastrointestinal dysbiosis and Clostridium botulinum in dairy cows, Anaerobe, 27, (100), (2014).
    • , Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies, Gastroenterology, 10.1053/j.gastro.2014.01.050, 146, 6, (1554-1563), (2014).
    • , Altered Egos: Antibiotic Effects on Food Animal Microbiomes, Annual Review of Microbiology, 68, 1, (297), (2014).
    • , The syndemics of childhood diarrhoea: A biosocial perspective on efforts to combat global inequities in diarrhoea-related morbidity and mortality, Global Public Health, 9, 7, (841), (2014).
    • , Food allergy and food‐based therapies in neurodevelopmental disorders, Pediatric Allergy and Immunology, 25, 3, (218-226), (2013).
    • , Development of the preterm infant gut microbiome: a research priority, Microbiome, 2, 1, (38), (2014).
    • , An Overview of the Microbiome and the Effects of Antibiotics, The Journal for Nurse Practitioners, 10, 7, (445), (2014).
    • , It's a gut feeling: How the gut microbiota affects the state of mind, The Journal of Physiology, 592, 14, (2981-2988), (2014).
    • , Gut microbiota, the pharmabiotics they produce and host health, Proceedings of the Nutrition Society, 10.1017/S0029665114001426, 73, 04, (477-489), (2014).
    • , Symbiosis as the way of eukaryotic life: The dependent co-origination of the body, Journal of Biosciences, 39, 2, (201), (2014).
    • , Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders, Biomarkers in Medicine, 8, 3, (331), (2014).
    • , Microbial genes, brain & behaviour – epigenetic regulation of the gut–brain axis, "Genes, Brain and Behavior", 13, 1, (69-86), (2013).
    • , Aging of the mammalian gastrointestinal tract: a complex organ system, AGE, 36, 3, (2014).
    • , Modulation of enteric neurons by interleukin‐6 and corticotropin‐releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome, The Journal of Physiology, 592, 23, (5235-5250), (2014).
    • , Friends with social benefits: host-microbe interactions as a driver of brain evolution and development?, Frontiers in Cellular and Infection Microbiology, 4, (2014).
    • , Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants, Applied Microbiology and Biotechnology, 98, 2, (563), (2014).
    • , The gastrointestinal tract microbiome, probiotics, and mood, Inflammopharmacology, 22, 6, (333), (2014).
    • , Neuro-active Compounds Produced by Probiotics, Interactive Probiotics, 10.1201/b16439-8, (2014).
    • , Microbiota and neurodevelopmental windows: implications for brain disorders, Trends in Molecular Medicine, 20, 9, (509), (2014).
    • , Use of probiotics in irritable bowel syndrome, Clinical Insights: Probiotics, Prebiotics and Gut Health, 10.2217/ebo.13.517, (105-117), (2014).
    • , Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-Related Disorders, PLoS ONE, 9, 12, (e114626), (2014).
    • , Beneficial modulation of the gut microbiota, FEBS Letters, 588, 22, (4120-4130), (2014).
    • , The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse, Neurogastroenterology & Motility, 25, 2, (183-e88), (2012).
    • , Beyond phylotyping: understanding the impact of gut microbiota on host biology, Neurogastroenterology & Motility, 25, 5, (358-372), (2013).
    • , Gut microbiota and gastrointestinal health: current concepts and future directions, Neurogastroenterology & Motility, 25, 1, (4-15), (2012).
    • , A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the Phospholipid Intervention for Cognitive Ageing Reversal (PLICAR): study protocol for a randomized controlled trial, Trials, 10.1186/1745-6215-14-404, 14, 1, (404), (2013).
    • , Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III – convergence toward clinical trials, Gut Pathogens, 5, 1, (4), (2013).
    • , The Future of Prebiotics and Probiotics, Probiotics and Prebiotics in Food, Nutrition and Health, 10.1201/b15561-24, (464-493), (2014).
    • , Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options, Scandinavian Journal of Gastroenterology, 48, 9, (995), (2013).
    • , The Pre- and Early Postnatal Microbiome: Relevance to Subsequent Health and Disease, NeoReviews, 14, 12, (e592), (2013).
    • , High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients, Anaerobe, 22, (50), (2013).
    • , Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats, Behavioral and Brain Functions, 9, 1, (46), (2013).
    • , The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Molecular Psychiatry, 18, 6, (666), (2013).
    • , Effects of the Modulation of Microbiota on the Gastrointestinal Immune System and Bowel Function, Journal of Agricultural and Food Chemistry, 61, 42, (9977), (2013).
    • , Potential applications of gut microbiota to control human physiology, Antonie van Leeuwenhoek, 104, 5, (609), (2013).
    • , Emerging importance of holobionts in evolution and in probiotics, Gut Pathogens, 5, 1, (12), (2013).
    • , Osteopathic manipulative treatment and nutrition: An alternative approach to the irritable bowel syndrome, Health, 05, 06, (87), (2013).
    • , Establishing a relationship between bacteria in the human gut and Complex Regional Pain Syndrome, Brain, Behavior, and Immunity, 29, (62), (2013).
    • , Consumption of Fermented Milk Product With Probiotic Modulates Brain Activity, Gastroenterology, 144, 7, (1394), (2013).
    • , Psychobiotics: A Novel Class of Psychotropic, Biological Psychiatry, 74, 10, (720), (2013).
    • , Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: Behavioral and electrophysiological proofs for microbiome–gut–brain axis, Neuroscience, 240, (287), (2013).
    • , The role of gut microbiota in the gut-brain axis: current challenges and perspectives, Protein & Cell, 4, 6, (403), (2013).
    • , Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents, American Journal of Physiology-Gastrointestinal and Liver Physiology, 304, 2, (G211), (2013).
    • , Effects of ceftriaxone‐induced intestinal dysbacteriosis on dendritic cells of small intestine in mice, Microbiology and Immunology, 57, 8, (561-568), (2013).
    • , Hot topics in gut microbiota, United European Gastroenterology Journal, 1, 5, (311), (2013).
    • , Review article: probiotics for the treatment of irritable bowel syndrome – focus on lactic acid bacteria, Alimentary Pharmacology & Therapeutics, 35, 4, (403-413), (2012).
    • , The Microbiota and Its Metabolites in Colonic Mucosal Health and Cancer Risk, Nutrition in Clinical Practice, 27, 5, (624-635), (2012).
    • , Chronic psychosocial stress induces visceral hyperalgesia in mice, Stress, 15, 3, (281), (2012).
    • , The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine, Beneficial Microbes, 3, 4, (251), (2012).
    • , Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut, Journal of Affective Disorders, 141, 1, (55), (2012).
    • , Stress and visceral pain: From animal models to clinical therapies, Experimental Neurology, 10.1016/j.expneurol.2011.04.020, 233, 1, (49-67), (2012).
    • , Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour, Nature Reviews Neuroscience, 10.1038/nrn3346, 13, 10, (701-712), (2012).
    • , Communication between gastrointestinal bacteria and the nervous system, Current Opinion in Pharmacology, 10.1016/j.coph.2012.09.010, 12, 6, (667-672), (2012).
    • , Investigating Functional Dyspepsia in Asia, Journal of Neurogastroenterology and Motility, 18, 3, (239), (2012).
    • , Nous Sommes Tous des Bacteries: Implications for medicine, pharmacology and public health, Biochemical Pharmacology, 84, 12, (1543), (2012).
    • , γ‐Aminobutyric acid production by culturable bacteria from the human intestine, Journal of Applied Microbiology, 113, 2, (411-417), (2012).
    • , Linkage of gut microbiome with cognition in hepatic encephalopathy, American Journal of Physiology-Gastrointestinal and Liver Physiology, 302, 1, (G168), (2012).
    • , Gut-central nervous system axis is a target for nutritional therapies, Nutrition Journal, 11, 1, (2012).
    • , The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial, BioPsychoSocial Medicine, 6, 1, (16), (2012).
    • , Probiotics in the Management of Functional Bowel Disorders, Gastroenterology Clinics of North America, 10.1016/j.gtc.2012.08.005, 41, 4, (805-819), (2012).
    • , A Symbiotic View of Life: We Have Never Been Individuals, The Quarterly Review of Biology, 87, 4, (325), (2012).
    • , Adapting to environmental stresses: the role of the microbiota in controlling innate immunity and behavioral responses, Immunological Reviews, 245, 1, (250-264), (2011).
    • , Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology, Psychoneuroendocrinology, 10.1016/j.psyneuen.2012.03.007, 37, 9, (1369-1378), (2012).
    • , ‘Omics’ of the mammalian gut – new insights into function, Current Opinion in Biotechnology, 23, 3, (491), (2012).
    • , Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome, Neuroscience & Biobehavioral Reviews, 36, 1, (310), (2012).
    • , Commensal communication to the brain: pathways and behavioral consequences, Microbial Ecology in Health & Disease, 23, 0, (2012).
    • , High-fat diet selectively protects against the effects of chronic social stress in the mouse, Neuroscience, 192, (351), (2011).
    • , Probiotics in the Treatment of Depression: Science or Science Fiction?, Australian & New Zealand Journal of Psychiatry, 45, 12, (1023), (2011).
    • , The Enteric Microbiota, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 10.4199/C00047ED1V01Y201110ISP029, 3, 9, (1-88), (2011).
    • , Influence of Gut Microbes on the Brain-Gut Axis (Gut 2011;60:307-317), Journal of Neurogastroenterology and Motility, 17, 4, (427), (2011).
    • , Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve, Proceedings of the National Academy of Sciences, 108, 38, (16050), (2011).
    • , Correlation of rRNA gene amplicon pyrosequencing and bacterial culture for microbial compositional analysis of faecal samples from elderly Irish subjects, Journal of Applied Microbiology, 111, 2, (467-473), (2011).
    • , Gut microbiota and the role of probiotics in therapy, Current Opinion in Pharmacology, 11, 6, (593), (2011).
    • , Gene-environment interaction in chronic disease: A European Science Foundation Forward Look, Journal of Allergy and Clinical Immunology, 128, 6, (S27), (2011).
    • , Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study, Journal of Neurogastroenterology and Motility, 10.5056/jnm.2011.17.3.213, 17, 3, (213-234), (2011).
    • , Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions, Comprehensive Physiology, (1339-1368), (2014).
    • , Oral microbiome activity in children with autism spectrum disorder, Autism Research, , (2018).
    • , 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders, Frontiers in Behavioral Neuroscience, 10.3389/fnbeh.2014.00396, 8, (2014).
    • , Computational profiling of the gut–brain axis: microflora dysbiosis insights to neurological disorders, Briefings in Bioinformatics, 10.1093/bib/bbx154, (2017).
    • , Neuromicrobiology: How Microbes Influence the Brain, ACS Chemical Neuroscience, 10.1021/acschemneuro.7b00373, (2017).
    • , Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests, PLOS ONE, 10.1371/journal.pone.0179739, 12, 6, (e0179739), (2017).
    • , “I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression, Frontiers in Psychiatry, 10.3389/fpsyt.2017.00153, 8, (2017).
    • , Efficacy of probiotics on anxiety—A meta‐analysis of randomized controlled trials, Depression and Anxiety, , (2018).
    • , Stress-Induced Visceral Pain: Toward Animal Models of Irritable-Bowel Syndrome and Associated Comorbidities, Frontiers in Psychiatry, 10.3389/fpsyt.2015.00015, 6, (2015).